AC
RH icon

Apogem Capital’s RH RH Stock Holding History

Apogem Capital’s Portfolio RH Stock Details RH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,000
Closed -$212K – 154
2022
Q2 		$212K Hold
1,000
– – 0.19% 135
2022
Q1 		$326K Buy
+1,000
New +$400K 0.22% 127

Other funds holding RH

Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCP
D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PC
Pelham Capital London, United Kingdom $176M AUM 37.46% 1-Year Est. Return

Apogem Capital's RH Position: Q3 2022 in Review

Apogem Capital sold out of RH (RH) in Q3 2022, closing a stake of 1,000 shares — an estimated $212K sold.

Apogem Capital first reported a position in RH in Q1 2022 and held it in 2 quarters. The position peaked at $326K in Q1 2022. 406 funds tracked by Wall St. Rank hold RH as of Q3 2022.

  • Apogem Capital reported no remaining RH position as of Q3 2022 after selling out during the quarter.
  • Apogem Capital sold 1,000 RH shares in Q3 2022, an estimated $212K.
  • Apogem Capital first reported a position in RH in Q1 2022 and held it in 2 quarters.
  • Apogem Capital's RH position peaked at $326K in Q1 2022.
  • 406 funds tracked by Wall St. Rank held RH as of Q3 2022.

Based on Apogem Capital's 13F filing for Q3 2022, filed 14 Nov 2022.